Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Prelude Therapeutics Inc (NASDAQ: PRLD) closed the day trading at $0.80 down -9.77% from the previous closing price of $0.89. In other words, the price has decreased by -$9.77 from its previous closing price. On the day, 0.59 million shares were traded.
Ratios:
For a better understanding of PRLD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.18 and its Current Ratio is at 5.18. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On June 20, 2024, Barclays Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $3.
On March 13, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $7.JMP Securities initiated its Mkt Outperform rating on March 13, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’25 when Combs Andrew bought 100,000 shares for $0.69 per share. The transaction valued at 69,250 led to the insider holds 480,123 shares of the business.
Vaddi Krishna bought 675,000 shares of PRLD for $467,438 on Mar 25 ’25. The CEO now owns 1,999,296 shares after completing the transaction at $0.69 per share. On Mar 21 ’25, another insider, Vaddi Krishna, who serves as the CEO of the company, bought 15,000 shares for $0.73 each. As a result, the insider paid 10,959 and bolstered with 1,324,296 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.45 while its Price-to-Book (P/B) ratio in mrq is 0.44.
Stock Price History:
Over the past 52 weeks, PRLD has reached a high of $6.80, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -0.35%, while the 200-Day Moving Average is calculated to be -52.03%.
Shares Statistics:
A total of 43.60M shares are outstanding, with a floating share count of 24.35M. Insiders hold about 56.88% of the company’s shares, while institutions hold 34.41% stake in the company.
